In 2019, 1.27 million people directly died through drug-resistant bacterial strains, which contributed to 4.95 million deaths. Researchers at the Free University of Berlin have found antimicrobial peptides (chains of amino acids that function as broad-spectrum antimicrobial compounds) to be effective at making bacteria less likely to develop resistance. This means continuous research into antimicrobial peptides is key to finding longer-lasting treatments for bacteria.
Don’t Forget About ERISA in Your Health Plan’s Cybersecurity Efforts: Important Reminders for Plan Fiduciaries in the Wake of Healthcare Cyberattack | Fisher Phillips
In response to a cyberattack on Change Healthcare, which resulted in unprecedented disruption to healthcare providers, the U.S. Department of Health and Human Services has
